Search images on Google Product Monograph
Active Ingredients:
- eribulin mesylate, 0.5 MG/ML
DIN: 02539136
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVENOUS
Description: SINGLE USE
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01X - OTHER ANTINEOPLASTIC AGENTS (ATC, WHO)
- L01XX - Other antineoplastic agents (ATC, WHO)
- L01XX41 - ERIBULIN (WHO)
Reference brand drug: Halaven